Decoy Therapeutics Inc. is trading 6.3% up at $6.45 on light, catalyst-free trading so far today.
- No fresh company-specific news, filings, analyst calls, or FDA/clinical headlines have appeared on major wires this morning.
- The stock’s jump appears to be an isolated biotech move rather than a reaction to macro headlines or broad index strength.
- Recent corporate items, such as the March 2026 reverse stock split, are considered too dated to explain today’s price action.